Maryland 2026 Session Status: Introduced Bipartisan · 9 R · 1 D cosponsors

HB0679 — Health Occupations - Cross-Sex Hormone Therapy for Minors

Last action — Hearing (Primary, House of Origin)

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House of Delegates. Introduced February 02, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 34% · moderate confidence

  • Introduced

    Current position in the legislative process.

  • 12 sponsors

    1 primary, 11 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (9 R · 1 D) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Prohibiting a licensed health care practitioner from prescribing, dispensing, or administering a cross-sex hormone or otherwise providing cross-sex hormone therapy for the treatment of a mental health diagnoses associated with gender nonconformity, including gender dysphoria, to an individual who is a minor.

Bill Text

We don't have the full text on file for this bill yet.

Read HB0679 on the official Maryland source →

Action History

  1. Hearing (Primary, House of Origin)

  2. First Reading (House of Origin)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 11 co-sponsors · 176 not signed on

Sponsors (1)

Co-sponsors (11)

Not signed on (176)

176 members have not signed on to this bill.

Show all 176 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB0679 do?
Prohibiting a licensed health care practitioner from prescribing, dispensing, or administering a cross-sex hormone or otherwise providing cross-sex hormone therapy for the treatment of a mental health diagnoses associated with gender nonconformity, including gender dysphoria, to an individual who is a minor.
Who sponsors HB0679?
HB0679 is sponsored by Delegate Grammer, Delegate Lauren Arikan (Republican), Delegate Christopher T. Adams (Republican), Delegate H. Kevin Anderson (Republican), Delegate Barry Beauchamp (Republican), Delegate Brian Chisholm (Republican), Delegate Mark N. Fisher (Republican), Delegate Nicholaus R. Kipke (Republican), Morgan, M., Delegate Ryan Nawrocki (Republican), Delegate Sheree Sample-Hughes (Democrat), and Delegate Kathy Szeliga (Republican).
What is the current status of HB0679?
This bill has been introduced in the House of Delegates. Introduced February 02, 2026. It must pass committee before a floor vote.
Where can I track HB0679?
Track HB0679 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB0679

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB0679

Last checked for changes about 23 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →